Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041168 · ClinicalTrials.gov registry record
Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors
A clinical trial, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- 414
- Enrollment target
NCT03041168: Clinical Trial study, sponsored by Thomas Jefferson University.
NCT03041168 is a clinical trial that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 414 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03041168 was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- 414 participants
- Enrollment target
Study Summary
The proposed study is evaluating a novel technology, Carotid Stenotic Scan (CSS), developed by the sponsor, CVR Global. Study Design. This is a prospective cohort study that will compare a new application of a technology, the CSS device, to reference standards for assessment of carotid disease.
Interventions
- DEVICE Carotid Stenotic Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-03-15 |
Why NCT03041168 stopped before completion
NCT03041168 is an observational study that tracks outcomes without assigning an intervention. The registered 414 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Carotid Stenotic Scan is the first listed.
NCT03041168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03041168 about?
NCT03041168 is a clinical study titled "Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors". The proposed study is evaluating a novel technology, Carotid Stenotic Scan (CSS), developed by the sponsor, CVR Global. Study Design. This is a prospective cohort study that will compare a new application of a technology, the CSS device, to reference standards for assessment of carotid disease.
What is the current status of trial NCT03041168?
This trial is currently terminated. The enrollment target is 414 participants. The study started on 2017-01. Estimated completion is 2018-03-15.
What interventions are being tested in trial NCT03041168?
The interventions under investigation include: Carotid Stenotic Scan (DEVICE).
Who is sponsoring clinical trial NCT03041168?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia